The U.S. government is pushing to redomesticate the manufacturing of pharmaceutical, biotech, gene therapy, and medical device products, both to bolster U.S. manufacturing generally and to address continuing shortages of...more
5/5/2025
/ Bayh-Dole Act ,
Biologics ,
Federal Funding ,
Federal Grants ,
Government Agencies ,
Healthcare ,
Intellectual Property Protection ,
Life Sciences ,
Manufacturing Facilities ,
Medical Devices ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Supply Chain ,
Tariffs